Online Course
07
Oct
2022
2022
08
Oct
2022
2022
Tumour sites
Breast Cancer in Young Women Sixth International Consensus Symposium - Online
Facebook
Linkedin
X
Send a mailChairs
Olivia Pagani, CH - Shani Paluch-Shimon, IL
Date
7-8 October 2022
Background
Olivia Pagani, CH - Shani Paluch-Shimon, IL
Date
7-8 October 2022
Background
Breast cancer in young women is a complex disease, occurring when women are at the peak of their reproductive years, family life and careers. Being a somewhat rare disease, the optimal management of these patients is based on scientific data derived from clinical trials mostly conducted on older women.
Many aspects of breast cancer in young women are therefore poorly understood (e.g., aetiology and biology among others) and research is much needed in this field. In addition, young women have many years ahead of them to suffer the long-term effects of treatment and specific survivorship issues (fertility and job, among others).
The Breast Cancer in Young Women Sixth International Consensus Symposium 2022 will address challenges and opportunities in different cultural and economic settings, follow-up care, diagnostic and treatment guidelines, from early to advanced breast cancer and survivorship, updating the available evidence and generating future research concepts and collaborations with an interactive, international, and collaborative spirit. It will also include a vote (not accessible to the public) on specific statements and a Panel Consensus Controversy Highlights that will form the basis for a Consensus Guidelines Manuscript to be published after the Symposium.
Learning Objectives
- In-depth learning and update of the scientific and clinical aspects of breast cancer in young women
- Highlighting of the importance of multi-disciplinary management
- Focus on clinical research priorities and future perspectives, involving patients’ advocates in setting the agenda
- Participation in the discussion of consensus guidelines
Target Group
Medical Oncologists – Surgeons – Gynaecologists – Radiation Oncologists – Breast Radiologists – Pathologists – Onco-geneticists – Nurses – Patient Advocates – Psycho-oncologists.
Format
The Symposium will be held online with the participation of world-renowned Experts.
The event will be accessible to the audience by registering on the SPCC e-learning platform OncoCorner. Material will remain available on-demand on the OncoCorner website.
Content
The event will consist of:
1. ON-DEMAND MATERIAL
2. CONSECUTIVE 2-DAY LIVE SESSIONS
RECORDED PRESENTATIONS are available via the following links:
2. CONSECUTIVE 2-DAY LIVE SESSIONS
RECORDED PRESENTATIONS are available via the following links:
SESSION 1: Challenges in the management of young women with germline predisposition
1) The ethical implications of increasing genetic testing and new paradigms in counseling – L. Battistuzzi, IT
2) Fertility preservation and pregnancy in mutation carriers – M. Lambertini, IT
3) Germline Genetic Testing for Breast Cancer: where are we heading? – C. Turnbull, UK
SESSION 2: Does financial toxicity impact patient care?
4) The surgical perspective - M.J. Cardoso, PT
5) The medical oncology perspective (focus on ABC) – A. Eniu, CH
6) The patient perspective – V. Sulosaari, FI
SESSION 3: New directions
7) Immune checkpoint inhibitors: for whom and when – G. Curigliano, IT
8) The role of PARP inhibitors in early and advanced disease – S. Paluch-Simon, IL
SESSION 4: What should we change in BCY6 guidelines?
9) Molecular testing in hormone positive early breast cancer – F. Cardoso, PT
10) Preoperative systemic treatment – K. Gelmon, CA
11) Target Therapies in Advanced Breast Cancer (ABC) – R. A. Dent, SG
12) Endocrine therapy – O. Pagani, CH
13) Escalation & de-escalation: progress made, challenges that remain – N. Harbeck, DE
SESSION 5: Follow-up care: focus on return to work
14) The Asian perspective – Q. Liu, CN
15) Return to work: The North American perspective – S. M. Rosenberg, US
16) Employment trajectories of young women with breast cancer: An ongoing prospective cohort study in Italy and Switzerland – M. Ruggeri, CH
SESSION 6: Pregnancy and breast cancer
17) Breast cancer during and after pregnancy: any difference? – F. Amant, BE
18) Pregnancy after breast cancer – F. A. Peccatori, IT
SESSION 7: Local therapy and quality-of-life outcomes in young women
19) The psycho-oncologist viewpoint – M. Braun, IL
20) The surgical viewpoint – O. D. Gentilini, IT
Continuing Medical Education accreditation
Request for Continuing Medical Education accreditation was submitted to ACOE.
The programme was recognised as being of high quality from both a scientific and didactic point of view and was awarded 6 CME credits.
Request for Continuing Medical Education accreditation was submitted to ACOE.
The programme was recognised as being of high quality from both a scientific and didactic point of view and was awarded 6 CME credits.
Acknowledgements
Sharing Progress in Cancer Care wishes to express its appreciation to AstraZeneca, Debiopharm, Eli Lilly and Company and Pfizer Inc. for their independent support via educational grants.
Disclosure of Auspices
EUSOMA: "Any recommendations, resolutions or other formal outcome(s) of this EUSOMA auspiced event does not necessarily reflect EUSOMA’s agreement or endorsement of any such outcomes".
07/10/2022 14:00 CEST
DAY 1
07/10/2022 14:00 CEST
Welcome and introduction
Chair: Olivia Pagani, CH
Chair: Shani Paluch-Shimon, IL
07/10/2022 14:10 CEST
Web-based Education and Supportive Care Intervention for Navigating AYAs through the Cancer Care Continuum
Expert: Ann H. Partridge, US
07/10/2022 14:30 CEST
Controversial key points on challenges in the management of young women with germline predisposition
Expert: Linda Battistuzzi, IT
Expert: Matteo Lambertini, IT
Expert: Clare Turnbull, UK
07/10/2022 14:35 CEST
Live Q&A and discussion
Expert: Linda Battistuzzi, IT
Expert: Matteo Lambertini, IT
Expert: Clare Turnbull, UK
Moderator: Giancarlo Pruneri, IT
07/10/2022 14:50 CEST
Controversial key points on the impact of financial toxicity on patient care
Expert: Maria-João Cardoso, PT
Expert: Alexandru Eniu, CH
Expert: Virpi Sulosaari, FI
07/10/2022 14:55 CEST
Live Q&A and discussion
Expert: Maria-João Cardoso, PT
Expert: Alexandru Eniu, CH
Expert: Virpi Sulosaari, FI
Moderator: Elzbieta Senkus, PL
07/10/2022 15:10 CEST
Controversial key points on new directions
Expert: Giuseppe Curigliano, IT
Expert: Shani Paluch-Shimon, IL
07/10/2022 15:15 CEST
Live Q&A and discussion
Expert: Giuseppe Curigliano, IT
Expert: Shani Paluch-Shimon, IL
Moderator: Hong Liu, CN
07/10/2022 15:30 CEST
Controversial key points on what should be changed in BCY6 guidelines
Expert: Fatima Cardoso, PT
Expert: Rebecca A. Dent , SG
Expert: Karen Gelmon, CA
Expert: Nadia Harbeck, DE
Expert: Olivia Pagani, CH
07/10/2022 15:40 CEST
Live Q&A and discussion
Expert: Fatima Cardoso, PT
Expert: Rebecca A. Dent , SG
Expert: Karen Gelmon, CA
Expert: Olivia Pagani, CH
Moderator: Ann H. Partridge, US
07/10/2022 16:00 CEST
Controversial key points on the follow-up care: focus on return to work
Expert: Qiang Liu, CN
Expert: Shoshana M. Rosenberg, US
Expert: Monica Ruggeri, CH
07/10/2022 16:05 CEST
Live Q&A and discussion
Expert: Qiang Liu, CN
Expert: Shoshana M. Rosenberg, US
Expert: Monica Ruggeri, CH
Moderator: Olivia Pagani, CH
07/10/2022 16:20 CEST
Controversial key points on pregnancy and breast cancer
Expert: Frédéric Amant, BE
Expert: Fedro Peccatori, IT
07/10/2022 16:25 CEST
Live Q&A and discussion
Expert: Frédéric Amant, BE
Expert: Matteo Lambertini, IT
Moderator: Hatem A. Azim Jr., EG
07/10/2022 16:40 CEST
Controversial key points on local therapy and quality-of-life outcomes in young women
Expert: Michal Braun, IL
Expert: Oreste D. Gentilini, IT
Expert: Philip Poortmans, BE
07/10/2022 16:45 CEST
Live Q&A and discussion
Expert: Michal Braun, IL
Expert: Philip Poortmans, BE
Moderator: Oreste D. Gentilini, IT
07/10/2022 17:00 CEST
Young Survival Coalition Project 528: The first-ever global needs assessment of young adults affected by breast cancer
Expert: Mary Farrell Ajango, US
07/10/2022 17:15 CEST
Closing Remarks
Chair: Olivia Pagani, CH
Chair: Shani Paluch-Shimon, IL
08/10/2022 14:00 CEST
DAY 2
08/10/2022 14:00 CEST
Welcome and introduction
Chair: Olivia Pagani, CH
Chair: Shani Paluch-Shimon, IL
08/10/2022 14:10 CEST
Patient advocate perspective: EUROPA DONNA
Expert: Tanja Spanic, SI
08/10/2022 14:20 CEST
Patient advocate perspective: YOUNG SURVIVAL COALITION
Expert: Jennifer Merschdorf, US
08/10/2022 14:40 CEST
Q&A and Live Discussion
Expert: Tanja Spanic, SI
08/10/2022 14:50 CEST
Panel Consensus Controversy Highlights
Chair: Olivia Pagani, CH
Chair: Shani Paluch-Shimon, IL
Expert: Hatem A. Azim Jr., EG
Expert: Maria-João Cardoso, PT
Expert: Giuseppe Curigliano, IT
Expert: Rebecca A. Dent , SG
Expert: Karen Gelmon, CA
Expert: Oreste D. Gentilini, IT
Expert: Matteo Lambertini, IT
Expert: Hong Liu, CN
Expert: Qiang Liu, CN
Expert: Jennifer Merschdorf, US
Expert: Ann H. Partridge, US
Expert: Philip Poortmans, BE
Expert: Giancarlo Pruneri, IT
Expert: Elzbieta Senkus, PL
Expert: Tanja Spanic, SI
Expert: Virpi Sulosaari, FI
08/10/2022 16:50 CEST
Closing Remarks
Chair: Olivia Pagani, CH
Chair: Shani Paluch-Shimon, IL
Mary Farrell Ajango
Young Survival Coalition, New York, USA
Frédéric Amant
University Hospitals of Leuven, Leuven, Belgium
Hatem A. Azim Jr.
Cairo Oncology Center, Cairo, Egypt
Linda Battistuzzi
University of Genoa, Genoa, Italy
Michal Braun
The Academic College of Tel Aviv Yaffo and Hadassah University Hospital, Jerusalem, Israel
Fatima Cardoso
Breast Unit, Champalimaud Clinical Center and ABC Global Alliance, Lisbon, Portugal
Maria-João Cardoso
Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal
Giuseppe Curigliano
University of Milan and European Institute of Oncology, Milan, Italy
Rebecca A. Dent
National Cancer Center Singapore, Singapore, Singapore
Alexandru Eniu
Interdisciplinary Cancer Service, HRC Hopital Riviera-Chablais, Rennaz, Switzerland
Karen Gelmon
BC Cancer Agency, Department of Medical Oncology, Vancouver, Canada
Oreste D. Gentilini
Vita-Salute San Raffaele University and San Raffaele Scientific Institute, Milan, Italy
Nadia Harbeck
Breast Center, LMU University Hospital, Munich, Germany
Matteo Lambertini
IRCCS Policlinico San Martino Hospital and University of Genoa, Genoa, Italy
Hong Liu
Tianjin Medical University Cancer Institute & Hospital (TJMUCH), Chinese Anti-Cancer Association (CACA), Tianjin, China
Qiang Liu
Sun Yat-sen Memorial Hospital, Guangzhou, China
Jennifer Merschdorf
Young Survival Coalition, New York, USA
Olivia Pagani
Geneva University Hospitals and Lugano University, Lugano, Switzerland
Shani Paluch-Shimon
Hadassah University Hospital - Sharett Institute of Oncology, Jerusalem, Israel
Ann H. Partridge
Harvard Medical School and Dana-Farber Cancer Institute, Boston, USA
Fedro Peccatori
Istituto Europeo di Oncologia IRCCS, Milan, Italy
Philip Poortmans
GZA Ziekenhuizen Campus Sint-Augustinus and Antwerp University, Antwerp, Belgium
Giancarlo Pruneri
Fondazione IRCCS, Istituto Nazionale Tumori and University of Milan, Milan, Italy
Shoshana M. Rosenberg
Weill Cornell Medicine, New York, USA
Monica Ruggeri
International Breast Cancer Study Group, Program for Young Patients, Bern, Switzerland
Elzbieta Senkus
Medical University of Gdansk, Gdansk, Poland
Tanja Spanic
Europa Donna, The European Breast Cancer and Europa Donna Slovenia, Ljubljana, Slovenia
Virpi Sulosaari
European Oncology Nursing Society (EONS) and Turku University of Applied Sciences, Turku, Finland
Clare Turnbull
The Institute of Oncology Research and Royal Marsden NHS Foundation Trust, London, United Kingdom
BREAST CANCER
PATIENT ADVOCACY
QUALITY OF LIFE